Evidence map›Paper›PMID 29295500›Full record

ArticleInternational journal of molecular sciences2017

Decitabine and Melphalan Fail to Reactivate p73 in p53 Deficient Myeloma Cells.

Pierre-Samuel Gillardin, Géraldine Descamps, Sophie Maiga, Benoit Tessoulin, Hanane Djamai, Benedetta Lucani, David Chiron, Philippe Moreau, Steven Le Gouill, Martine Amiot and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Pierre-Samuel GillardinCRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, 44007 Nantes, France. pierre.gillardin@etu.univ-nantes.fr.
Géraldine DescampsCRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, 44007 Nantes, France. geraldine.descamps@univ-nantes.fr.
Sophie MaigaCRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, 44007 Nantes, France. sophie.maiga@inserm.fr.
Benoit TessoulinCRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, 44007 Nantes, France. benoit.tessoulin@chu-nantes.fr.
Hanane DjamaiCRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, 44007 Nantes, France. djamai.hanane@gmail.com.
Benedetta LucaniCRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, 44007 Nantes, France. benedetta.lucani@gmail.com.
David ChironCRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, 44007 Nantes, France. david.chiron@inserm.fr.ORCID 0000-0002-2199-752X
Philippe MoreauCRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, 44007 Nantes, France. philippe.moreau@chu-nantes.fr.
Steven Le GouillCRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, 44007 Nantes, France. steven.legouill@chu-nantes.fr.
Martine AmiotCRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, 44007 Nantes, France. martine.amiot@inserm.fr.
Catherine Pellat-DeceunynckCRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, 44007 Nantes, France. catherine.pellat-deceunynck@univ-nantes.fr.
Agnès Moreau-AubryCRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, 44007 Nantes, France. agnes.aubry@univ-nantes.fr.
Centre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background:

Indexed as

AzacitidineBase SequenceCell Line, TumorCisplatinCpG IslandsDecitabineDNA MethylationGene Expression Regulation, NeoplasticHumansMelphalanMultiple MyelomaTumor Protein p73Tumor Suppressor Protein p53AzacitidineCisplatinDecitabineMelphalanTumor Protein p73Tumor Suppressor Protein p53alkylating drugsCpG methylationdecitabinemultiple myelomap53p73

Identifiers

PMID29295500
PMCPMC5795990
OpenAlexW2778558461

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.